PD Therapeutics 2009: Poster Abstracts
The Michael J. Fox Foundation for Parkinson’s Research & The New York Academy of Sciences
Parkinson’s Disease Therapeutics Conference
New York, NY
September 30, 2009
Poster Session on Novel Therapeutic Targets and Tools
Thomas G. Beach, MD, PhD, Sun Health Research Institute – “Brain & Body Donation Program of the Arizona Parkinson’s Disease Consortium” Abstract
Steven P. Braithwaite, PhD, Wyeth Pharmaceuticals – “Targeting LRRK2 for Drug Discovery” Abstract
Luke A. Esposito, PhD, ProteoTech Inc. “New Small Molecule Inhibiting Agents of Alpha-Synuclein & Lewy Body Formation as Disease-Modifying Treatments for Parkinson's Disease”
Mark Frasier, PhD, The Michael J. Fox Foundation – “The Parkinson’s Progression Markers Initiative: A Prospective Biomarkers Study” Abstract
David Grabli, MD, Hôpital de la Salpêtrière – “Development of a New Primate Model of Postural Disturbance by Lesioning Non Cholinergic Neurons of the Reticular Formation”
Ann M. Graybiel and Jill Crittenden, MIT – “Evaluation of the Striatum-Enriched Genes, CalDAG-GEF1 and CalDAG-GEF2, as Targets for the Treatment and Prevention of L-DOPA Induced Dyskinesias” Abstract
Chenjian Li, PhD, Weill Medical College of Cornell University – “BAC-Engineered Alpha-Synuclein Transgenic Rats” Abstract
Pamela J. McLean, PhD, Harvard University – “Hsp90 as a Target for Neuroprotective Agents in Parkinson's Disease” Abstract
Michael T. Rogan, PhD, The Michael J. Fox Foundation – “PD Online Research: A Professional Collaborative Community for Rapid-Fire Problem Solving in Parkinson’s Disease Science” Abstract
